Efficacy and Safety of Befotertinib (D-0316) in Patients With EGFR T790M-Mutated NSCLC That Had Progressed After Prior EGFR Tyrosine Kinase Inhibitor Therapy: A Phase 2, Multicenter, Single-Arm, Open-Label StudyShun Lü, Shucai Zhang, Hong Jian et al.|Journal of Thoracic Oncology|2022Cited by 25
The X-Age Project to construct a Chinese aging clockShiqing Feng, Mengmeng Jiang, Qiaoran Wang et al.|Nature Aging|2025Cited by 11
Exploring the Antifibrotic Potential of the heparan sulfate mimetic OTR4120: Insights from Preclinical ModelsManuela Marega, Savério Bellusci, Najet Mejdoubi‐Charef et al.|bioRxiv (Cold Spring Harbor Laboratory)|2024Cited by 0
Exploring the antifibrotic potential of the heparan sulfate mimetic OTR4120Manuela Marega, Savério Bellusci, Najet Mejdoubi‐Charef et al.|Unknown|2025Cited by 0
LSC - 2025 - Exploring the antifibrotic potential of the heparan sulfate mimetic OTR4120Manuela Marega, Savério Bellusci, Najet Mejdoubi‐Charef et al.|Unknown|2025Cited by 0